United Therapeutics Corp. | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
174,560.00
340,074.00
651,639.00
713,700.00
417,900.00
589,200
Depreciation, Depletion & Amortization
31,259.00
32,245.00
32,921.00
31,600.00
31,000.00
35,900
Other Funds
9,299.00
30,845.00
37,426.00
5,900.00
-
28,900
Funds from Operations
641,933.00
740,814.00
584,946.00
761,000.00
552,600.00
654,000
Changes in Working Capital
216,666.00
385,555.00
202,185.00
117,400.00
78,400.00
124,400
Net Operating Cash Flow
425,267.00
355,259.00
382,761.00
643,600.00
474,200.00
778,400
Capital Expenditures
31,910.00
47,439.00
49,792.00
43,200.00
86,300.00
Sale of Fixed Assets & Businesses
-
-
-
-
8,300.00
Purchase/Sale of Investments
263,064.00
385,904.00
203,371.00
91,500.00
757,700.00
Net Investing Cash Flow
294,974.00
338,465.00
503,579.00
48,300.00
835,600.00
Issuance/Reduction of Debt, Net
1,320.00
177,800.00
133,150.00
15,600.00
249,300.00
Net Financing Cash Flow
5,115.00
576,535.00
446,943.00
497,700.00
43,300.00
Net Change in Cash
124,859.00
113,439.00
434,101.00
191,200.00
317,900.00
Free Cash Flow
393,357.00
307,820.00
332,969.00
605,600.00
387,900.00
Deferred Taxes & Investment Tax Credit
104,343.00
185,106.00
-
-
-
-
Other Sources
-
-
350,000.00
-
100.00
Change in Capital Stock
13,094.00
429,580.00
351,219.00
488,000.00
206,000.00
Exchange Rate Effect
319.00
3,750.00
5,296.00
3,000.00
200.00
About United Therapeutics
View Profile
